An algorithm for the classification of untoward events in large scale clinical trials

Area of Science:

• Pharmacovigilance
• Clinical Trial Methodology
• Drug Safety Assessment

Background:

• Adverse event analysis in clinical trials is crucial for drug safety.
• Existing methods for causality assessment can be complex and subjective.
• A standardized approach is needed for reliable event classification.

Purpose of the Study:

• To develop and validate a reproducible algorithm for assessing the probability of drug-relatedness of adverse events.
• To present the algorithm as a user-friendly decision table.
• To apply the algorithm in a real-world clinical trial setting.

Main Methods:

• Algorithm development based on Karch and Lasagna's proposal.
• Presentation of the algorithm in a decision table format.
• Assessment of inter-rater reliability for the algorithm's judgments.
• Application of the algorithm to classify adverse events from an anti-inflammatory drug trial.

Main Results:

• The developed algorithm provides a five-point scale for classifying event-drug relationships.
• The algorithm demonstrated a good degree of reproducibility in judgments.
• Successful classification of all untoward events in an extended clinical trial was achieved.

Conclusions:

• The proposed decision table algorithm offers a standardized and reproducible method for assessing drug-relatedness of adverse events.
• This tool enhances the analysis of safety data in large-scale clinical trials.
• The algorithm's utility is confirmed through its application in an anti-inflammatory drug trial.